Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Monday, September 29

8:35 AM - 8:55 AM PT

Question and Answers
Speaker: Bukolt, Katherine, MSN, APRN, FNP-C, AOCNP - Texas Oncology - Baylor Charles A. Sammons Cancer Center, Dallas, TX
8:40 AM - 8:50 AM PT

181 - Validation of a Digital Twin-Based Clinical Trial Design Approach Combining Radiotherapy and Tyrosine Kinase Inhibitors: Prospective Virtual Trial Predictions Match Real-World Data
Speaker: McClatchy, David, PhD - Massachusetts General Hospital, Boston, MA
8:40 AM - 8:50 AM PT

187 - A Phase IV Surveillance Trial of Pencil Beam Scanning Proton Therapy in Children
Speaker: Lucas, John, MD, MS - St. Jude Children's Research Hospital, Memphis, TN
8:40 AM - 8:50 AM PT

192 - A Novel Therapeutic Approach Using ENO1-specific CAR-NK Cells to Target KRAS-Mutated Cancers
Speaker: Chao, K.S. Clifford, MD - China Medical University, Taiwan, Taichung, Taichung
8:50 AM - 9:00 AM PT

182 - Predictive Modeling Radiation-Induced Visual Field Deficits for Early Toxicity Detection
Speaker: Thariat, Juliette, MD, PhD - Centre François Baclesse, Caen, Normandy
8:50 AM - 9:00 AM PT

Discussant
Speaker: Casey, Dana, MD - University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC
8:50 AM - 9:00 AM PT

Discussant
Speaker: Young, Kristina, MD, PhD - Earle A. Chiles Research Institute, Portland, OR
8:55 AM - 9:00 AM PT

Closing
Speaker: Robin, Tyler, MD, PhD - University of Colorado School of Medicine, Deptartment of Radiation Oncology, Aurora, CO
8:55 AM - 9:00 AM PT

Closing
Speaker: Tate, Molly, PhD, MSN, APRN, FNP-C - MD Anderson Cancer Center, Houston, TX
10:45 AM - 10:55 AM PT

193 - Quality of Life Results from NRG-GU005: A Phase III Trial of SBRT vs. Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer
Speaker: Yu, James, MD, FASTRO, MHS - Dartmouth Hitchcock Medical Center, Lebanon, NH
10:45 AM - 10:55 AM PT

199 - Improved Progression-Free and Overall Survival with Radiotherapy Consolidation Post-Autologous Stem Cell Transplant in Patients with Relapsed/Refractory Aggressive Lymphoma with Pre-Transplant Partial Metabolic Response on FDG-PET
Speaker: Abeyakoon, Chathuri, MBBS - Princess Margaret Cancer Center, University Health Network, Toronto, ON
10:45 AM - 10:55 AM PT

204 - Contralateral Esophageal-Sparing Technique Reduces High-Grade Esophagitis in Locally Advanced Small Cell Lung Cancer: Updated Results from a Randomized Trial
Speaker: Xu, Yaping, PhD - Shanghai Pulmonary Hospital, Shanghai, Shanghai